论文部分内容阅读
目的:分析研究匹多莫德联合童康片用于小儿反复呼吸道感染的临床疗效。方法:选取到我院就诊的214例小儿反复呼吸道感染患者,用随机数字法均分为两组,观察组和对照组,观察组采用匹多莫德联合童康片进行治疗,对照组仅采用匹多莫德进行治疗,分析比较两组的临床疗效。结果:观察组治疗总有效率92.52%明显高于对照组82.24%,统计学比较差异显著(P<0.05);无效率明显低于对照组,统计学比较差异显著(P<0.05);两组均无明显毒副作用。结论:匹多莫德联合同康片用于小儿反复呼吸道感染的治疗,临床疗效满意,毒副作用不明显,安全可靠有效,值得在临床应用中推广。
Objective: To analyze the clinical efficacy of pidotimod in combination with Tong Kang tablets in children with recurrent respiratory tract infections. Methods: A total of 214 children with recurrent respiratory tract infection in our hospital were selected and randomly divided into two groups: the observation group and the control group. The observation group was treated with Pidotimod in combination with Tong Kang Tablet while the control group only with Pidotimod for treatment, analysis and comparison of the clinical efficacy of the two groups. Results: The total effective rate of the observation group was 92.52%, which was significantly higher than that of the control group (82.24%), the difference was statistically significant (P <0.05); the inefficiency was significantly lower than that of the control group (P <0.05) No obvious side effects. Conclusion: Pidotimod and Tongkang tablets are used in the treatment of recurrent respiratory tract infections in children. The clinical efficacy is satisfactory, the side effects are not obvious, safe, reliable and effective, which is worth to be popularized in clinical application.